BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lok KH, Hung HG, Ng CH, Kwong KC, Yip WM, Lau SF, Li KK, Li KF, Szeto ML. Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong. J Gastroenterol Hepatol. 2008;23:406-410. [PMID: 17623033 DOI: 10.1111/j.1440-1746.2007.05079.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences. J Dig Dis. 2010;11:134-147. [PMID: 20579217 DOI: 10.1111/j.1751-2980.2010.00429.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 112] [Article Influence: 9.4] [Reference Citation Analysis]
2 Sewell JL, Yee HF, Inadomi JM. Hospitalizations are increasing among minority patients with Crohnʼs disease and ulcerative colitis: . Inflammatory Bowel Diseases 2010;16:204-7. [DOI: 10.1002/ibd.21008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
3 Qiu Y, Ren W, Liu Y, Chen WE, Pan XH, Ren JJ. Disease burden of inflammatory bowel disease in China from 1990 to 2017: Findings from the global burden of diseases 2017. EClinicalMedicine 2020;27:100544. [PMID: 33150321 DOI: 10.1016/j.eclinm.2020.100544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sahu KK, Minz S, Kaurav M, Pandey RS. Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis. Artif Cells Nanomed Biotechnol 2016;44:642-53. [PMID: 25379956 DOI: 10.3109/21691401.2014.975239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Ye L, Cao Q, Cheng J. Review of inflammatory bowel disease in China. ScientificWorldJournal. 2013;2013:296470. [PMID: 24348149 DOI: 10.1155/2013/296470] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
6 Abdul Rani R, Raja Ali RA, Lee YY. Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place. Intest Res 2016;14:297-304. [PMID: 27799880 DOI: 10.5217/ir.2016.14.4.297] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
7 Qu Y, Miao YL. Stem cell transplantation for the treatment of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2010; 18(35): 3772-3777 [DOI: 10.11569/wcjd.v18.i35.3772] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Chen CY, Lee KT, Charles Tzu-Chi L, Lai WT, Huang YB. Epidemiology and Disease Burden of Ulcerative Colitis in Taiwan: A Nationwide Population-Based Study. Value Health Reg Issues 2013;2:127-34. [PMID: 29702840 DOI: 10.1016/j.vhri.2013.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
9 van Geenen EM, Sachar DB. Infliximab in Crohn's Disease-associated Toxic Megacolon. Journal of Clinical Gastroenterology 2012;46:321-3. [DOI: 10.1097/mcg.0b013e31822a29c7] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
10 Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, O’Morain C, Moum B, Colombel JF. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630-649. [PMID: 23335431 DOI: 10.1007/s11894-013-0313-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
11 Sewell JL, Inadomi JM, Yee HF. Race and inflammatory bowel disease in an urban healthcare system. Dig Dis Sci. 2010;55:3479-3487. [PMID: 20936350 DOI: 10.1007/s10620-010-1442-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
12 Ouyang Q, Xue LY. Inflammatory bowel disease in the 21(st) century in China: turning challenges into opportunities. J Dig Dis. 2012;13:195-199. [PMID: 22435503 DOI: 10.1111/j.1751-2980.2012.00579.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
13 Zhiqin W, Palaniappan S, Raja Ali RA. Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future. Intest Res 2014;12:194-204. [PMID: 25349593 DOI: 10.5217/ir.2014.12.3.194] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
14 Ye CA, Gao YJ, Ge ZZ, Dai J, Li XB, Xue HB, Ran ZH, Zhao YJ. PillCam colon capsule endoscopy versus conventional colonoscopy for the detection of severity and extent of ulcerative colitis. J Dig Dis. 2013;14:117-124. [PMID: 23134295 DOI: 10.1111/1751-2980.12005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
15 Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res Clin Gastroenterol. 2014;28:363-372. [PMID: 24913377 DOI: 10.1016/j.bpg.2014.04.003] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 10.6] [Reference Citation Analysis]
16 Jalili A, Mertz KD, Romanov J, Wagner C, Kalthoff F, Stuetz A, Pathria G, Gschaider M, Stingl G, Wagner SN. NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivo. PLoS One 2013;8:e69064. [PMID: 23935925 DOI: 10.1371/journal.pone.0069064] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
17 Zhang WF, Yang Y, Su X, Xu DY, Yan YL, Gao Q, Duan MH. Deoxyschizandrin suppresses dss-induced ulcerative colitis in mice. Saudi J Gastroenterol 2016;22:448-55. [PMID: 27976641 DOI: 10.4103/1319-3767.195552] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol. 2009;104:2100-2109. [PMID: 19471256 DOI: 10.1038/ajg.2009.190] [Cited by in Crossref: 124] [Cited by in F6Publishing: 123] [Article Influence: 9.5] [Reference Citation Analysis]
19 Kim JH, Cheon JH, Park Y, Lee HJ, Park SJ, Kim TI, Kim WH. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission. Scand J Gastroenterol 2016;51:1069-74. [PMID: 26895215 DOI: 10.3109/00365521.2016.1150503] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
20 Kedia S, Ahuja V. Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East. Inflamm Intest Dis. 2017;2:102-115. [PMID: 30018961 DOI: 10.1159/000465522] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
21 Ng SC. Changing Epidemiology and Future Challenges of Inflammatory Bowel Disease in Asia. Intest Res 2010;8:1. [DOI: 10.5217/ir.2010.8.1.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Kim JY, Park DI, Han DS, Huh KC, Lee CK, Shin JE, Kim JH, Kim YS, Jung Y, Jung SA, Song HJ, Jang HJ, Kim YH, Hong SN. Comparing the clinical outcomes of young-onset and adult-onset ulcerative colitis: a multi-center Korean Association for the Study for Intestinal Diseases study. Korean J Intern Med 2017;32:69-78. [PMID: 27338135 DOI: 10.3904/kjim.2014.262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
23 Yang X, Geng J, Meng H. Glucocorticoid receptor modulates dendritic cell function in ulcerative colitis. Histol Histopathol 2020;35:1379-89. [PMID: 32706033 DOI: 10.14670/HH-18-241] [Reference Citation Analysis]
24 Jin Y, Lin L, Lin Y, Zheng C. Exogenous carcinoembryonic antigen-related cell adhesion molecule 1 suppresses 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in mice. Journal of Surgical Research 2015;195:113-20. [DOI: 10.1016/j.jss.2015.01.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
25 Yun J, Xu CT, Pan BR. Epidemiology and gene markers of ulcerative colitis in the Chinese. World J Gastroenterol 2009; 15(7): 788-803 [PMID: 19230040 DOI: 10.3748/wjg.15.788] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
26 Anzai H, Hata K, Kishikawa J, Ishii H, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H, Kazama S, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Watanabe T. Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression. Colorectal Dis 2016;18:O97-O102. [DOI: 10.1111/codi.13237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
27 Wu J, Cheng Y, Zhang R, Shen H, Ma L, Yang J, Zhang Y, Zhang J. Evaluating the Association of Common Variants of the SLC44A4 Gene with Ulcerative Colitis Susceptibility in the Han Chinese Population. Genet Test Mol Biomarkers 2017;21:555-9. [PMID: 28753073 DOI: 10.1089/gtmb.2017.0010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
28 Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54. quiz e30. [PMID: 22001864 DOI: 10.1053/j.gastro.2011.10.001] [Cited by in Crossref: 2653] [Cited by in F6Publishing: 2489] [Article Influence: 241.2] [Reference Citation Analysis]
29 Alireza Taghavi S, Reza Safarpour A, Hosseini SV, Noroozi H, Safarpour M, Rahimikazerooni S. Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A Review of 740 Patients in Fars Province, Southern Iran. Ann Colorectal Res 2013;1:17-22. [DOI: 10.17795/acr-11477] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
30 Prideaux L, Kamm MA, De Cruz P, Williams J, Bell SJ, Connell WR, Brown SJ, Lust M, Desmond PV, Chan H. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne. J Gastroenterol Hepatol. 2012;27:919-927. [PMID: 22098103 DOI: 10.1111/j.1440-1746.2011.06984.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
31 Thomas T, Chandan JS, Li VSW, Lai CY, Tang W, Bhala N, Kaplan GG, Ng SC, Ghosh S. Global smoking trends in inflammatory bowel disease: A systematic review of inception cohorts. PLoS One 2019;14:e0221961. [PMID: 31545811 DOI: 10.1371/journal.pone.0221961] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
32 Abdullah M, Syam AF, Simadibrata M, Gunawan J, Makmun D, Rani AA. New insights on the pathomechanisms of inflammatory bowel disease: New insights on IBD pathomechanisms. Journal of Digestive Diseases 2013;14:455-62. [DOI: 10.1111/1751-2980.12081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
33 Zhu F, Li QZ, Jin SZ, Qu B. Role of ginsenoside in treatment of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2014; 22(20): 2870-2874 [DOI: 10.11569/wcjd.v22.i20.2870] [Reference Citation Analysis]
34 Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Curr Gastroenterol Rep. 2019;21:40. [PMID: 31338613 DOI: 10.1007/s11894-019-0705-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 16.3] [Reference Citation Analysis]
35 Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 2012;27:1266-80. [PMID: 22497584 DOI: 10.1111/j.1440-1746.2012.07150.x] [Cited by in Crossref: 195] [Cited by in F6Publishing: 196] [Article Influence: 19.5] [Reference Citation Analysis]
36 Lok KH, Ng CH, Hung HG, Li KF, Li KK, Szeto ML. Correlation of serum biomarkers with clinical severity and mucosal inflammation in Chinese ulcerative colitis patients: Biomarkers in Chinese UC patients. Journal of Digestive Diseases 2008;9:219-24. [DOI: 10.1111/j.1751-2980.2008.00350.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
37 Ramakrishna BS, Makharia GK, Abraham P, Ghoshal UC, Jayanthi V, Agarwal BK, Ahuja V, Bhasin DK, Bhatia SJ, Choudhuri G. Indian Society of Gastroenterology consensus on ulcerative colitis. Indian J Gastroenterol. 2012;31:307-323. [PMID: 23096266 DOI: 10.1007/s12664-012-0259-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
38 Hong JT, Kim ER, Park SW, Kim JW, Hong SN, Chang DK, Kim YH, Cho JH. Long-term Prognosis of Localized Lymphoid Hyperplasia of the Rectum. Gut Liver 2021;15:77-84. [PMID: 32062874 DOI: 10.5009/gnl19288] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Chow DK, Leong RW, Tsoi KK, Ng SS, Leung WK, Wu JC, Wong VW, Chan FK, Sung JJ. Long-term follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol. 2009;104:647-654. [PMID: 19262521 DOI: 10.1038/ajg.2008.74] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 4.4] [Reference Citation Analysis]
40 Ooi CJ, Fock KM, Makharia GK, Goh KL, Ling KL, Hilmi I, Lim WC, Kelvin T, Gibson PR, Gearry RB. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol. 2010;25:453-468. [PMID: 20370724 DOI: 10.1111/j.1440-1746.2010.06241.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 8.1] [Reference Citation Analysis]
41 Kim HJ, Hann HJ, Hong SN, Kim KH, Ahn IM, Song JY, Lee SH, Ahn HS. Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study. Inflamm Bowel Dis. 2015;21:623-630. [PMID: 25647154 DOI: 10.1097/mib.0000000000000313] [Cited by in Crossref: 98] [Cited by in F6Publishing: 51] [Article Influence: 14.0] [Reference Citation Analysis]
42 Jia X, Guo R, Hu Z, Liu J, Liu J, Li B, Yang Q, He J. Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis. Medicine (Baltimore) 2020;99:e22894. [PMID: 33126341 DOI: 10.1097/MD.0000000000022894] [Reference Citation Analysis]
43 Ng SC, Leung WK, Shi HY, Li MK, Leung CM, Ng CK, Lo FH, Hui YT, Tsang SW, Chan YK. Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong. Inflamm Bowel Dis. 2016;22:1954-1960. [PMID: 27416041 DOI: 10.1097/mib.0000000000000846] [Cited by in Crossref: 61] [Cited by in F6Publishing: 26] [Article Influence: 15.3] [Reference Citation Analysis]
44 Zhao J, Ng SC, Lei Y, Yi F, Li J, Yu L, Zou K, Dan Z, Dai M, Ding Y, Song M, Mei Q, Fang X, Liu H, Shi Z, Zhou R, Xia M, Wu Q, Xiong Z, Zhu W, Deng L, Kamm MA, Xia B. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease. Inflamm Bowel Dis 2013;19:1839-45. [PMID: 23669403 DOI: 10.1097/MIB.0b013e31828a6551] [Cited by in Crossref: 13] [Cited by in F6Publishing: 48] [Article Influence: 1.6] [Reference Citation Analysis]
45 Chuang CH, Lin SH, Chen CY, Sheu BS, Kao AW, Wang JD. Increasing incidence and lifetime risk of inflammatory bowel disease in Taiwan: a nationwide study in a low-endemic area 1998-2010. Inflamm Bowel Dis. 2013;19:2815-2819. [PMID: 24141711 DOI: 10.1097/01.MIB.0000435436.99612.27] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
46 Kang HS, Koo JS, Lee KM, Kim DB, Lee JM, Kim YJ, Yoon H, Jang HJ. Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use. World J Gastroenterol 2019; 25(8): 989-1001 [PMID: 30833804 DOI: 10.3748/wjg.v25.i8.989] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Park J, Cheon JH. Incidence and Prevalence of Inflammatory Bowel Disease across Asia. Yonsei Med J 2021;62:99-108. [PMID: 33527789 DOI: 10.3349/ymj.2021.62.2.99] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Jin X, Chen YP, Chen SH, Xiang Z. Association between Helicobacter Pylori infection and ulcerative colitis--a case control study from China. Int J Med Sci. 2013;10:1479-1484. [PMID: 24046521 DOI: 10.7150/ijms.6934] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
49 Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659-665. [PMID: 19424654 DOI: 10.1007/s00535-009-0057-3] [Cited by in Crossref: 168] [Cited by in F6Publishing: 166] [Article Influence: 12.9] [Reference Citation Analysis]
50 Park SJ, Kim WH, Cheon JH. Clinical characteristics and treatment of inflammatory bowel disease: A comparison of Eastern and Western perspectives. World J Gastroenterol 2014; 20(33): 11525-11537 [PMID: 25206259 DOI: 10.3748/wjg.v20.i33.11525] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 65] [Article Influence: 8.3] [Reference Citation Analysis]
51 Shi J, Zhou L, Zhernakova A, Qian J, Zhu F, Sun G, Zhu L, Ma X, Dijkstra G, Wijmenga C. Haplotype-based analysis of ulcerative colitis risk loci identifies both IL2 and IL21 as susceptibility genes in Han Chinese. Inflamm Bowel Dis. 2011;17:2472-2479. [PMID: 21648020 DOI: 10.1002/ibd.21652] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
52 Lee JH, Cheon JH, Kim ES, Chung MJ, Kang W, Kim DH, Ha YJ, Park JJ, Kim TI, Kim WH. The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis. Dig Dis Sci 2010;55:1406-12. [PMID: 19507028 DOI: 10.1007/s10620-009-0847-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
53 Lee HS, Park SH, Yang SK, Lee J, Soh JS, Lee S, Bae JH, Lee HJ, Yang DH, Kim KJ, Yea BD, Byeon JS, Myung SJ, Yoon YS, Yu CS, Kim JH. Long-term prognosis of ulcerative colitis and its temporal change between 1977 and 2013: a hospital-based cohort study from Korea. J Crohns Colitis. 2015;9:147-155. [PMID: 25518059 DOI: 10.1093/ecco-jcc/jju017] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 8.5] [Reference Citation Analysis]
54 Nagahori M, Nemoto Y, Watanabe M. Pathogenesis of Inflammatory Bowel Diseases. Intest Res 2010;8:9. [DOI: 10.5217/ir.2010.8.1.9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
55 Kusunoki Y, Kido Y, Naito Y, Kon R, Mizukami N, Kaneko M, Wakui N, Machida Y, Ikarashi N. Changes in the Pharmacokinetics of Phenytoin in Dextran Sulfate Sodium–Induced Ulcerative Colitis in Mice. Int J Toxicol 2017;36:485-91. [DOI: 10.1177/1091581817735987] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
56 Danese S, Banerjee R, Cummings JF, Dotan I, Kotze PG, Leong RWL, Paridaens K, Peyrin-Biroulet L, Scott G, Assche GV, Wehkamp J, Yamamoto-Furusho JK. Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach. Intest Res 2018;16:522-8. [PMID: 30321913 DOI: 10.5217/ir.2018.00073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
57 Choi JH, Kim ES, Cho KB, Park KS, Lee YJ, Lee SM, Kang YJ, Jang BI, Kim KO; Daegu-Gyeongbuk Gastrointestinal Study Group (DGSG). Old age at diagnosis is associated with favorable outcomes in korean patients with inflammatory bowel disease. Intest Res 2015;13:60-7. [PMID: 25691844 DOI: 10.5217/ir.2015.13.1.60] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]